HLA Class I B8 Antibody, anti-human, PE-Vio® 770, REAfinity™, 30 tests in 300 µL
文献支持

HLA Class I B8 Antibody, anti-

human, PE-Vio® 770, REAfinity™, 30 tests in 300 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-099-609
  • 2025年12月09日
  • Flow cytometry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      HLA Class I B8

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,2-8℃

    • 克隆性

      REA145

    • 标记物

      PE-Vio 770

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Flow cytometry

    • 浓度

      1:11

    • 抗体英文名

      HLA Class I B8 Antibody, anti-human, REAfinity™

    • 抗体名

      HLA Class I B8 Antibody, anti-human, REAfinity™

    • 规格

      30 tests in 300 µL

    Identification and enumeration of HLA class I B8+ cells by flow cytometryClone REA145 recognizes HLA B8, a class I human leukocyte antigen (HLA). Expressed on the surface of most nucleated cells, class I molecules are heterodimeric molecules and consist of a type I integral membrane α heavy chain and soluble β2 microglobulin protein. The extracellular region of the heavy chain further consists of three domains, of which one comprises the peptide binding groove. Antigens binding to class I molecules are 8–10 amino acids long and play an important role in recognition of the virus infected and malignant cells by cytotoxic T lymphocytes (CTLs). In addition, class I molecules interact with NK cell receptors to modulate the activity of NK cells. | Additional information: Clone REA145 displays negligible binding to Fc receptors.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Jahnsen, F. L. et al. (2018) Transcriptional and functional profiling defines human small intestinal macrophage subsets. J. Exp. Med. 215 (2): 441–458. | Hewitt, E. W. et al. (2003) The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110 (2): 163–169. | Edvardsen, K. et al. (2016) Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. J. Transl. Med. 14: 68.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月09日询价
    ¥2200
    爱必信(上海)生物科技有限公司
    2025年07月12日询价
    ¥2429
    朗智(上海)生物科技有限公司
    2025年08月06日询价
    ¥1698
    苏州奕赛生物科技有限公司
    2025年07月09日询价
    文献支持
    HLA Class I B8 Antibody, anti-human, PE-Vio® 770, REAfinity™, 30 tests in 300 µL
    询价